Aromatase activity in human osteoblast-like osteosarcoma cell

Area of Science:

• Endocrinology
• Cell Biology
• Biochemistry

Background:

• Osteosarcoma cells (HOS) are a model for studying bone cell function.
• Aromatase is a key enzyme in estrogen biosynthesis.
• Glucocorticoids are known to influence various cellular processes.

Purpose of the Study:

• To investigate aromatase activity in cultured human osteosarcoma cells (HOS).
• To determine the effect of dexamethasone on HOS aromatase activity.
• To elucidate the mechanism of glucocorticoid regulation on aromatase in these cells.

Main Methods:

• Cultured human osteosarcoma cells (HOS) were incubated with varying concentrations of dexamethasone (10(-10) M to 10(-5) M) for 12 to 72 hours.
• Aromatase activity was quantified by measuring the release of [3H]H2O from the conversion of [1 beta-3H]androstenedione to estrone.
• Enzyme kinetics, including Vmax and Km, were analyzed.

Main Results:

• HOS cells exhibit intrinsic aromatase activity with an apparent Km of 4.46 +/- 0.98 nM for androstenedione.
• Dexamethasone treatment significantly increased aromatase activity in a dose-dependent manner (10(-9) M to 10(-5) M).
• Dexamethasone elevated the Vmax of aromatase activity without altering its Km value.

Conclusions:

• Osteoblastic cells, represented by HOS, possess functional aromatase activity.
• Glucocorticoids, such as dexamethasone, can regulate and enhance aromatase activity in osteoblastic cells.
• These findings suggest that osteoblastic cells can directly convert androgens to estrogens, with this process being modulated by glucocorticoids.